Cetkovic-Cvrlje, Marina <br/><br/>
Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  Mar 2003 
 - 213-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1521-6616 
<br/><br/><label>Standard No.: </label>10.1016/s1521-6616(02)00049-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adoptive Transfer<br/>Animals<br/>Cytokines--biosynthesis<br/>DNA-Binding Proteins--metabolism<br/>Diabetes Mellitus, Type 1--prevention & control<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--therapeutic use<br/>Female<br/>Interleukin-2--pharmacology<br/>Janus Kinase 3<br/>Lymphocyte Activation--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred NOD<br/>Milk Proteins<br/>Ovalbumin--immunology<br/>Phosphorylation<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Quinazolines--pharmacology<br/>STAT5 Transcription Factor<br/>T-Lymphocytes--drug effects<br/>Trans-Activators--metabolism<br/>Tyrosine--metabolism